Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$27,000.00

Monitoring lung health during ex vivo lung perfusion using a rapid novel technique: methylation-sensitive restriction enzyme quantitative PCR

EF 2024-25

Résumé
Lung transplantation is a lifesaving intervention for patients with end-stage lung disease. However, the demand for lungs exceeds the number of available donor lungs. Ex vivo lung perfusion (EVLP) is a strategy developed to address this concern. In this strategy, the donor lung is flushed with a solution, known as perfusate, and is kept breathing at body temperature in a plastic chamber. Lungs can also be repaired and treated before transplantation. The implementation of EVLP led to a 70% increase in annual transplants by the Toronto EVLP program. Cell-free DNA (cfDNA) is DNA released from dying cells; it can be extracted from perfusate during or after EVLP to provide insight into donor lung health. Methylation analysis of cfDNA reveals which cells are dying because cell types have unique methylation profiles. DNA methylation is the addition of methyl groups to DNA, which contributes to the unique functions of different cell types. Current methylation profiling methods take weeks to complete. A rapid methylation profiling strategy for EVLP use (~3-12 hours) is required to monitor lung health before transplantation. I propose a technique that uses methylation-sensitive enzymes (MSRE) and DNA quantification (qPCR). The MSREs cut DNA at unmethylated cut sites. Extracted cfDNA will be digested with MSREs or left undigested. The difference between undigested and digested DNA will represent cell death for each cell type. A machine learning model will be developed to predict the lung quality before transplantation based on the MSRE-qPCR results of cell-type death. Overall, this MSRE-qPCR protocol can be completed within the hours of EVLP, estimate cell-type death, and predict the overall health of donor lungs before transplantation.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
529690
Name
Fiallos Herrera Carolina D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Monitoring lung health during ex vivo lung perfusion using a rapid novel technique: methylation-sensitive restriction enzyme quantitative PCR
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cell-Free Dna; Ex Vivo Lung Perfusion; Lung Disease; Lung Transplantation; Methylation-Sensitive Restriction Enzymes; Quantitative Pcr
Abstract
Lung transplantation is a lifesaving intervention for patients with end-stage lung disease. However, the demand for lungs exceeds the number of available donor lungs. Ex vivo lung perfusion (EVLP) is a strategy developed to address this concern. In this strategy, the donor lung is flushed with a solution, known as perfusate, and is kept breathing at body temperature in a plastic chamber. Lungs can also be repaired and treated before transplantation. The implementation of EVLP led to a 70% increase in annual transplants by the Toronto EVLP program. Cell-free DNA (cfDNA) is DNA released from dying cells; it can be extracted from perfusate during or after EVLP to provide insight into donor lung health. Methylation analysis of cfDNA reveals which cells are dying because cell types have unique methylation profiles. DNA methylation is the addition of methyl groups to DNA, which contributes to the unique functions of different cell types. Current methylation profiling methods take weeks to complete. A rapid methylation profiling strategy for EVLP use (~3-12 hours) is required to monitor lung health before transplantation. I propose a technique that uses methylation-sensitive enzymes (MSRE) and DNA quantification (qPCR). The MSREs cut DNA at unmethylated cut sites. Extracted cfDNA will be digested with MSREs or left undigested. The difference between undigested and digested DNA will represent cell death for each cell type. A machine learning model will be developed to predict the lung quality before transplantation based on the MSRE-qPCR results of cell-type death. Overall, this MSRE-qPCR protocol can be completed within the hours of EVLP, estimate cell-type death, and predict the overall health of donor lungs before transplantation.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fiallos Herrera, Carolina D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~